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a b s t r a c t
There is an increasing interest in developing novel macromolecular vehicles for the intracellular and
controlled delivery of bioactive molecules, since they can allow modulation of the cellular functions in
a more effective manner ex vivo, and maintain the cellular phenotype in vivo upon re-implantation. The
present study was designed to investigate the effect of combining novel dexamethasone-loaded car-
boxymethylchitosan/poly(amidoamine) dendrimer (Dex-loaded CMCht/PAMAM) nanoparticles and, both
HA and SPCL scaffolds (3D system) on the proliferation and osteogenic differentiation of rat bone marrow
stromal cells (RBMSCs) in vitro. A luminescent cell viability assay using RBMSCs was performed for
screening cytotoxicity of the developed HA and SPCL scaffolds. Results corroborated previous ones which
have demonstrated in vitro, the superior performance of the HA and SPCL scaffolds on supporting cells
adhesion and proliferation. Furthermore, this work showed that RBMSCs seeded onto the surface of both
HA and SPCL scaffolds differentiate into osteoblasts when cultured in the presence of 0.01 mg ml!1 Dex-
loaded CMCht/PAMAM dendrimer nanoparticles. In addition, results demonstrated that Dex-loaded
CMCht/PAMAM dendrimer nanoparticles combined with the HA enhance osteogenesis by increasing ALP
activity and mineralization of the extra-cellular matrix. The pre-incubation of stem cells with these kinds
of nanoparticles allows the delivery of Dex inside the cells and directly influences their cellular fate,
being a promising new tool to be used in cells and tissue engineering strategies.
! 2008 Elsevier Ltd. All rights reserved.
1. Introduction
Mesenchymal stem cells (MSCs) are a valuable therapeutic tool
in tissue engineering (TE) [1], since they can proliferate and
differentiate either in vitro or in vivo into a multitude of distinct
cellular phenotypes [2–4]. It is well known that the process of
stem cell maintenance and differentiation occurs in vitro, under
optimal culture conditions [5,6]. For example, it has been shown
that dexamethasone (Dex) delivered as a medium supplement
promotes the osteogenic differentiation of marrow stromal cells
[4,7]. Despite its use in clinical practice [8], Dex and other gluco-
corticoids have been restricted to few applications mainly due to
adverse side-effects [9,10]. Therefore, the development of novel
strategies that can stimulate stem cells to become osteoblasts in
vitro and in vivo, and that provide a more effective treatment route
with diminished complications is still regarded as a hot issue [11]
that needs to be exploited further. In this context, the use of
nanocarriers that possess high cellular uptake efficiency to deliver
and target drugs can be seen as a possible and reliable solution [12].
Ultimately, these vehicles are expected to increase the solubility of
drugs [13] and their bioavailability [14], and their delivery to the
targets where they are required [15,16], thus suppressing harmful
secondary effects on the patients during drug/cell-based
treatments.
A huge portfolio of controlled-release vehicles is being investi-
gated for their ability to process into nanocarriers [17,18], while
several new emerging nanomaterials are being studied for their
biodegradability [19,20] and for their controlled-release and
stimuli–responsive properties [21,22]. In this context, we focus our
present work on the surface engineering of poly(amidoamine)
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(PAMAM) dendrimers with natural-based and biodegradable
polymers such as the water-soluble carboxymethylchitosan
(CMCht) [23]. Previously [24], we have clearly demonstrated that
the CMCht/PAMAM dendrimer nanoparticles are efficiently inter-
nalized by different cell types. Since glucocorticoids bind to and
activate a cytoplasmatic glucocorticoid receptor [25,26], our
particular interest is in the loading of these novel macromolecular
architectures with Dex in order to study their internalization and
effects on the proliferation and osteogenic differentiation of stem
cells, in vitro and in vivo.
In this work, we applied a TE strategy consisting of the combi-
nation of stem cells and either ceramic or polymeric scaffolds as
away to qualitatively and quantitatively evaluate their performance
in supporting the osteogenic differentiation of rat bone marrow
stromal cells (RBMSCs) exposed to the intracellular Dex-loaded
CMCht/PAMAMdendrimer nanocarrier. The herein chosen scaffolds
were the macroporous HA [27] and SPCL [28,29] scaffolds which
have been found to exhibit a unique architecture and adequate
physicochemical andbiological properties to beused in bone related
applications. However, the novelty of the present paper lies in
deeper in vitro studies that illustrated the potential applications of
combining nanoparticles and scaffolds for cells and tissue engi-
neering. Therefore, we went a step further and reported on the
osteogenic efficacy of this system, and how to make use of this
potential in bone TE and regenerativemedicine. In vitro studieswere
carried out in order to evaluate the viability of RBMSCs seeded onto
the surface of the HA and SPCL scaffolds. In addition, RBMSCs-scaf-
fold constructs’ specimens were also examined using microscopic
analyses to assess the cell adhesion and proliferation. Complemen-
tarily, scanning electron microscopy, LIVE/DEAD viability assay and
DNA quantificationwere carried out after 14 d of culturing. Alizarin
red and ALP stainings were also performed to qualitatively assess
calciumdeposition and ALP activity, which are parameters denoting
osteogenic differentiation. Quantification of the alkaline phospha-
tase activity and osteocalcin content was carried out in order to
evaluate the osteoblastic phenotype expression levels.
2. Materials and methods
2.1. Preparation of the hydroxyapatite (HA) and starch–polycaprolactone (SPCL)
scaffolds
HA scaffolds were prepared by impregnating a polyurethane sacrifice sponge
(PU, 5 mm diameter and 4 mm height, Eurospuma S.A., Portugal) with HA powders
obtained as previously reported [27]. The elimination of the organic matrix con-
sisted of burning the impregnated sponges in a furnace (Fornoceraˆmica-ATR 901,
Portugal) at 900 #C for 24 h, then sintering at 1300 #C for 3 h.
Starch–polycaprolactone (SPCL) scaffolds were produced by adopting a two step
procedure as previously reported elsewhere [28]. The material used was a blend of
starchwith approximately 70% byweight of poly-3-caprolactone, SPCL. Briefly, fibres
of SPCL were produced by melt spinning using a modular co-rotating twin screw
extruder in two consecutive steps to a final draw ratio of approximately 1:100. Then,
melt spun fibres were chopped. Fibre bundles were randomly displaced into the
custom-designed mould cavities and subjected to thermal treatment at 60 #C for
30 min before compression and fibre bonding. SPCL scaffolds (5 mm diameter and
4 mm height) were obtained through cutting of fibre bonded meshes with a circular
die. Standardized fabrication conditions enabled the production of scaffolds with
67.4 $ 1.3% porosity (as determined by micro-computed tomography). More details
on SPCL scaffolds can be found elsewhere [30,31].
Prior to the cell culture studies HA and SPCL scaffolds were sterilized in an
ethylene oxide gas atmosphere.
2.2. Synthesis of dexamethasone-loaded carboxymethylchitosan/poly(amidoamine)
(Dex-loaded CMCht/PAMAM) dendrimer nanoparticles
Carboxymethylchitosan (CMCht) was synthesized by a chemical modification
of chitin (Sigma, Germany) as described by Chen et al. [32]. Starburst" poly-
(amidoamine)-carboxylic terminated dendrimers, PAMAM-CT (generation 1.5, 20%
(w/v) methanolic solution) with an ethylenediamine core were purchased from
Aldrich. CMCht/PAMAM dendrimer nanoparticles were prepared stepwise as
previously reported [24]. Succinctly, Dex-loaded CMCht/PAMAM dendrimer nano-
particles were prepared by means of mixing CMCht/PAMAM dendrimer
nanoparticles in an aqueous solution with a dexamethasone (Dex) solution with
a final concentration of 5 % 10!4 M, under vigorous agitation. The mixture was then
added to the precipitation media consisting of a saturated sodium carbonate
(Aldrich, Germany) and acetone solution. Precipitates were collected and extensive
dialysis (cellulose tubing, benzoylated for separating compounds with a cut-off of
1200 from Sigma, Germany) was carried out for 2 d. Dex-loaded CMCht/PAMAM
dendrimer nanoparticles were obtained by freezing the solution at !80 #C and
freeze-drying (Telstar-Cryodos-80, Spain).
2.3. Characterization of the HA and SPCL scaffolds, and Dex-loaded CMCht/PAMAM
dendrimer nanoparticles
2.3.1. Surface topography characterization
The surface morphology and pore size of the HA scaffolds and SPCL scaffolds
were examined under a scanning electron microscope, SEM (SM-300, Topcon
Corporation, Tokyo, Japan). Prior to microstructure analysis, specimens were sputter
coatedwith platinum using an Ion coater (IB-3, Eiko Engineering Ltd., Ibaraki, Japan)
with a current set at 6 mA, for a coating time of 2–3 min.
2.3.2. Micro-computed tomography
The qualitative and quantitative information about the microstructure of the HA
and SPCL scaffolds was obtained by micro-computed tomography, m-CT 20 equip-
ment (SCANCO Medicals, Switzerland). The X-ray scans were acquired in high
resolution mode of 11 mm x/y/z [27]. Mimics" (Materialise, Belgium) was used as
image processing software for CT reconstruction to create and visualize the 3D
representations.
2.3.3. Transmission electron microscopy
The morphology of the Dex-loaded CMCht/PAMAM dendrimer nanoparticles
was investigated by transmission electron microscopy, TEM (Philips CM-12, FEI
Company, The Netherlands, equipped with a MEGA VIEW-II DOCU camera and
Image Software Analyzer SIS NT DOCU). The nanoparticles were stained with 2% of
phosphotungstic acid and placed on copper grids for observation.
2.4. In vitro cell culture studies
2.4.1. Isolation and culturing of rat bone marrow stromal cells (RBMSCs)
Seven-week-old Fischer 344/N male rats were purchased from Japan SLC Inc.
(Shizuoka, Japan) and sacrificed in accordance with the Ethics Committee at the
Tissue Engineering Research Center (Amagasaki, Japan). The epiphyseal regions of
the femora were removed and marrow plugs in the femoral shafts were flushed out
using Eagle’s minimum essential medium (MEM, Nacalai Tesque, Japan) supple-
mented with 15% fetal bovine serum, FBS (JRH Biosciences, USA) and 1% antibiotic–
antimycotic (Nacalai Tesque, Japan) solution. The RBMSCs isolation was performed
under aseptic conditions. RBMSCs were transferred to a T75 cm2 culture flask and
expanded in the presence of complete MEMmedium at 37 #C in a 5% CO2 incubator.
Then, the culturemediumwas changed every 2 or 3 d. After reaching confluency, the
cells (passage 1, P1) were released from substratum with 1 ml of 0.05% trypsin–
0.53 mM EDTA (Invitrogen, USA) and centrifuged at 900 rpm for 5 min. A cell
suspensionwas prepared and cell concentration determined using an automatic cell
counter (Cell Counter Sysmex F-520, Japan).
Viability of the RBMSCs was also analyzed with a NucleoCounter (ChemoMetec
A/S, Denmark) as described elsewhere [33].
2.4.2. Cytotoxicity screening of the HA and SPCL scaffolds
A luminescent cell viability assay [24] based on the adenosine triphosphate
(ATP) quantification was performed in order to evaluate the viability of RBMSCs
seeded onto the surface of the HA and SPCL scaffolds. Prior to RBMSCs seeding,
the HA and SPCL scaffolds were pretreated (de-airation) to prevent air bubble
formation in the pores. Scaffolds were placed in 10 ml polystyrene tubes with
ventilation caps. MEM medium was added and scaffolds were de-aired under
vacuum using a 20 ml syringe with an attached 21G needle. Then, each scaffold
was transferred into the respective well of a non-adherent 96-well tissue culture
polystyrene (TCPS) plate. RBMSCs (P1) were seeded onto the surface of the HA
and SPCL scaffolds at a cell density of 5 % 102 cells/scaffold, 1 % 103 cells/scaf-
fold, 5 % 103 cells/scaffold and 1 % 104 cells/scaffold, and cultured in MEM
medium under static conditions for 24 h, 3 and 7 d. After each time period, the
ATP content which signals the presence of metabolically active cells was
measured by means of performing a CellTiter-Glo" luminescent cell viability
assay (Promega Corporation, USA). Luminescence was measured in a microplate
reader (Wallac ARVOsx 1420, Perkin–Elmer Life and Analytical Sciences, USA),
following the protocol provided by the supplier. All experiments were carried
out 3 times using 3 replicates per experimental condition.
2.4.3. Assessment of proliferation and osteogenic differentiation of RBMSCs seeded
onto the surface of the HA and SPCL scaffolds and cultured with Dex-loaded CMCht/
PAMAM dendrimer nanoparticles
RBMSCswere isolated and expanded as mentioned above. HA and SPCL scaffolds
were placed in each well of a 96-well TCPS plate. Then, 1 % 106 RBMSCs (P1) were
added per each HA and SPCL scaffold, and the constructs were cultured in complete
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MEMmedium under standard culture conditions for the period of 12 h to allow cell
adhesion. After that time, cell-scaffold constructs were transferred to a non-treated
and non-protein coated flat bottom 12-well TCPS plate (Nunc, Japan), the different
culture mediumwas added, and RBMSCs were cultured for times up to 14 d. RBMSCs
were exposed to a MEM medium supplemented with 0.01 mg ml!1 Dex-loaded
CMCht/PAMAM dendrimer nanoparticles, 0.28 mM ascorbic acid (Wako Pure
Chemicals, Japan) and 10 mM b-glycerophosphate (Sigma, USA). RBMSCS were also
cultured in a complete MEM medium (negative control for osteogenic differentia-
tion). A complete MEM medium supplemented with 10!8 M Dex, 0.28 mM ascorbic
acid and 10 mM b-glycerophosphate was used as the positive control for osteogenic
differentiation. All experiments were carried out 3 times using a minimum of 3
replicates per experimental condition.
2.4.4. LIVE/DEAD viability assay
Cell adhesion and proliferation were also investigated with a LIVE/DEAD
viability assay kit (Molecular Probes, USA) after 14 d of culturing. RBMSCs-scaffold
constructs were incubated with two probes, calceı´n-AM (green colour) and
ethidium homodimer-1 (bright red colour), for intracellular esterase activity and
plasma membrane integrity, respectively [34]. Then, RBMSCs-scaffold construct
specimens were washed with Ca and Mg-free PBS solution and observed under a 3D
Fig. 1. SEM micrographs of the HA (A–B) and SPCL (C–D) scaffolds.
Fig. 2. 3D m-CT images of the HA (A) and SPCL (B) scaffolds.
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fluorescence microscope (Olympus SZX12 stereomicroscope, OLYMPUS Co. Ltd.,
Japan). RBMSCs-scaffold constructs’ specimens were also prepared for SEM obser-
vation using standard fixative and dehydration methods.
2.4.5. DNA quantification
DNA quantification was performed using the nuclear dye Hoechst 33258
(Nacalai Tesque, Japan) according to the method previously described [34]. Prior to
the assay, the RBMSCs-scaffold constructs were washed with a Ca and Mg-free PBS
solution. Then, constructs were transferred to a 2 ml eppendorf, pulverized with
zirconia’s balls (milling time of w2 min at 25 shakes s!1) using a ball mixer mill
(Retsch GmbH, Germany), and sonicated in 0.2% Triton-X (Nacalai Tesque, Japan)
solution for 5 min. Finally, the samples were sonicated and the DNA quantification
carried out. The standard DNA solutions were prepared using salmon sperm DNA
(Invitrogen, USA).
2.4.6. Qualitative analysis of mineralization
Alizarin red S staining was performed to investigate possible calcium deposition
after 14 d of culturing. RBMSCs-scaffold construct specimens were washed twice
with Ca and Mg-free PBS solution and cells fixed with 95% ethanol for 15 min [35].
The fixed cells were thenwashed oncewith PBS and stained with 5mgml!1 Alizarin
red S in Ca andMg-free PBS solution for 5 min at room temperature. After a washing
step with ultra-pure water, RBMSCs-scaffold construct specimens were examined
under a 3D fluorescence microscope.
2.4.7. Qualitative and quantitative analysis of alkaline phosphatase (ALP)
ALP activity was investigated either qualitatively and quantitatively in order to
evaluate osteoblastic differentiation. For the ALP staining the RBMSCs-scaffold
construct specimens were washed twice with PBS, after 14 d of culturing. Cells were
fixed with 4% paraformaldehyde/Ca andMg-free PBS solution for 15 min at 4 #C. The
RBMSCs-scaffold construct specimens were washed twice with AMP buffer (56 mM
of 2-amino-2-methyl-1,3-propanediol in ultra-pure water, pH 9.9) and then soaked
with staining solution 0.5 mg naphtol AS-MX phosphate and 0.5 mg fast red violet
LB salt per ml, in AMP buffer. RBMSCs-scaffold construct specimens were incubated
for 10 min at room temperature, washed with Ca and Mg-free PBS solution and
examined under a 3D fluorescence microscope.
The remaining sonicated suspensions obtained from the DNA quantification
assay were used to determine ALP levels. Prior to analysis the samples were soni-
cated once and centrifuged at 12,000 rpm for 1 min at 4 #C. To each well of a 96-well
plate, an aliquot of supernatant and p-nytrophenyl phosphate substrate (ZYMED"
Laboratories, Invitrogen, USA), was added following the method described else-
where [33] with minor modifications. Standards were prepared with p-nytrophenol,
pNP. Triplicates were made for each sample and standard. Absorbance was read at
405 nm (Wallac ARVOsx 1420, Perkin–Elmer Life and Analytical Sciences, USA), and
sample concentrations were read off from the standard graph. Enzyme activity was
expressed as nmol of pNP released/scaffold/30 min and normalized by DNA content.
2.4.8. Osteocalcin content determined by enzyme-linked immunosorbent assay
(ELISA)
The remnants of each sample used for the ALP/DNA assays were treated with
a 20% formic acid solution and stored at 4 #C for 2–3 d. After that time, samples were
centrifuged at 15,000 rpm for 10 min at 4 #C. The supernatant was passed through
a Sephadex#G-25 column (GE healthcare, Sweden) for de-salting, and concentrated
in order to carry out the ELISA assay. A Rat Osteocalcin EIA kit (No. BT-460,
Biomedical Technologies Inc., MA, USA) was used following the instructions
provided by the supplier. Data was read off from the standard curve obtained with
human osteocalcin and expressed as ng of deposited osteocalcin per mg of DNA.
3. Results and discussion
3.1. Morphology of the HA and SPCL scaffolds, and Dex-loaded
CMCht/PAMAM dendrimer nanoparticles
It is well known that the ability of a scaffold to support cells
proliferation and differentiation is one of the key issues for the
success of a tissue engineered cells-scaffold construct. In the
current work, an extensive in vitro study was carried out in order to
investigate the effect of the intracellular delivery of dexamethasone
by the carboxymethylchitosan/poly(amidoamine) dendrimer (Dex-
loaded CMCht/PAMAM) nanoparticles supplemented from
a culture medium on the proliferation and osteogenic differentia-
tion of RBMSCs when cultured onto the surface of two types of
scaffolds. From Fig. 1, it is possible to observe the microstructure of
the HA (A–B) and SPCL (C–D) scaffolds examined under SEM. Fig.1A
and B revealed that the architecture of the obtained HA scaffolds
possess a trabeculae-like structure and highly interconnected
macropores. Fig. 1C and D shows the typical SPCL macroporosity
which can be obtained by randomly assembling the fibres. The
polymeric scaffolds also exhibited a high level of interconnectivity.
Fig. 3. TEM image showing the morphology of the Dex-loaded CMCht/PAMAM den-
drimer nanoparticles.
Fig. 4. Cell viability assay of RBMSCs seeded at different cell densities onto the surface of the HA and SPCL scaffolds after 24 h, 3 d and 7 d: (C1) 5 % 102 cells/scaffold (C2) 1 % 103
cells/scaffold, (C3) 5 % 103 cells/scaffold, and (C4) 1 % 104 cells/scaffold. Cell numbers correlate with luminescence. Results expressed as an average $ standard deviation, n ¼ 9.
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Several groups [27,29,31] have shown that these scaffolds exhibit
adequate porosity andmechanical properties to support cell adhesion
and proliferation and tissue ingrowth upon implantation of the
construct. Moreover, we have also demonstrated that these starch-
based scaffolds are biodegradable, and thus have the potential to be
used in tissueengineering strategies to regenerate bone tissuedefects.
Fig. 2 shows the 3D micro-computed tomography images of the
HA and SPCL scaffolds. This study revealed that the HA scaffolds
possess a mean porosity of 67.8 $ 5.1% and pore size in the range of
50–600 mm. The SPCL scaffolds showed a mean porosity of
67.4 $ 1.3% and pore size in the range of 50–1000 mm. The selected
scaffolds present a similar porosity and pore size as well as high
levels of interconnectivity, which is ideal for carrying out
a comparative study in terms of scaffold composition as these
features play a critical role in bone formation in vitro and in vivo
[36]. Issues that will not be addressed in the present work are of
course related to the mechanical properties and degradation rate of
the scaffolds, but more details on this can be found elsewhere [31].
Fig. 3 shows the TEM image of the developedDex-loaded CMCht/
PAMAM dendrimer nanoparticles. It can be seen that the novel
macromolecular nanocarriers possess a dendron-like morphology.
These have been shown to be effective in the loading and controlled
Fig. 5. DNA content of RBMSCs seeded (1 %106 cells/scaffold) onto the surface of the HA (left) and SPCL (right) scaffolds and cultured for 12 h, 7 and 14 d, in different culture media:
(A, B and E) Complete MEM medium; (C, F) MEM medium supplemented with 10!8 M Dex, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate (osteogenic medium); (D, G) MEM
mediumwith 0.01 mg ml!1 Dex-loaded CMCht/PAMAM dendrimer nanoparticles, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate. Results expressed as an average $ standard
deviation, n ¼ 9.
Fig. 6. SEM and respective fluorescence microscopy (calceı´n-AM, green colour) images of the HA (left) and SPCL (right) scaffolds seeded with RBMSCs (1 % 106 cells/scaffold) after
culturing in different culture media for the period of 14 d: (A–D) Complete MEM medium; (E–H) MEM medium with 0.01 mg ml!1 Dex-loaded CMCht/PAMAM dendrimer
nanoparticles, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate; (I–L) MEM medium supplemented with 10!8 M Dex, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate
(osteogenic medium). It is also possible to observe that cells perfectly adhere, spread actively and presented a flatten morphology (*).
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release of Dex [24]. In this study,wehave also demonstrated that the
Dex-loaded CMCht/PAMAM dendrimer nanoparticles did not
exhibit significant cytotoxicity in the range of concentrations below
1mgml!1 and fluorescent probe labelled nanoparticles were found
to be internalized with high efficiency by different cell types. In this
first study, we also proved that the Dex-loaded CMCht/PAMAM
dendrimer nanoparticles promote the osteogenic differentiation of
rat bone marrow stromal cells in a 2D system, in vitro.
3.2. Rat bone marrow stromal cells viability, adhesion and
proliferation
A luminescent cell viability assay based on adenosine triphos-
phate (ATP) quantification was performed to evaluate the viability
of RBMSCs seeded at different cell densities onto the surface of the
HA and SPCL scaffolds, and results are disclosed in Fig. 4. This assay
is a feasible test for assessing the cytotoxicity of materials, since it
signals the presence of metabolically active cells. Results have
shown that the HA and SPCL materials are not cytotoxic over
RBMSCs. As seen in the present work, no significant differences in
the RBMSCs viability were observed when culturing on the surface
of the HA as compared to the SPCL scaffolds. By its turn, it is
possible to observe that the initial RBMSCs seeding density affects
the viability (ATP content) of RBMSCs.
Additional studies were carried out to evaluate the capacity of
HA and SPCL scaffolds to support the proliferation and differenti-
ation of rat bone marrow stromal cells (RBMSCs) after exposure to
Dex-loaded CMCht/PAMAM dendrimer nanoparticles.
In the present paper, RBMSCs proliferation was investigated by
DNA quantification (Fig. 5). From that figure it is possible to observe
that the cell seeding efficiency is similar for HA and SPCL scaffolds
as observed by the DNA content after 12 h of culturing. However,
a slightly higher cellular density was detected for the HA as
compared to that for SPCL, after 7 and 14 d. This result shows that
the HA scaffolds allow for a higher proliferation of the RBMSCs. To
a certain extent, this observation may also be related with the fact
that proliferation rates are reduced during differentiation [37], as
seen by lower cell numbers in cultures when osteogenic factors
were present. Then, RBMSCs-scaffold constructs were also exam-
ined under microscopic analyses in order to assess cell adhesion
and proliferation, after 14 d of culturing (Fig. 6). It is possible to
observe a higher cellular density on the surface of the HA as
compared to the SPCL. This data thus reflects the findings of the
DNA quantification. This data also indicates that cells adhere
perfectly, spread actively, and present a flattened morphology (*).
Moreover, the (calcein-AM, green colour) images of the RBMSCs-
HA and SPCL constructs revealed that cells were alive, after 14 d (for
interpretation of colour in Fig. 6, the reader is referred to the web
Fig. 7. Optical microscopy and respective SEM images of the HA (left) and SPCL (right) scaffolds seeded with RBMSCs (1 % 106 cells/scaffold), which were stained with Alizarin red
(mineralization) after culturing in different culture media for the period of 14 d: (A–D) Controls (scaffolds without RBMSCs); (E–H) Complete MEM medium; (I–L) MEM medium
with 0.01 mg ml!1 Dex-loaded CMCht/PAMAM dendrimer nanoparticles, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate; (M–P) MEM medium supplemented with 10!8 M
Dex, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate (osteogenic medium).
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Fig. 8. Optical microscopy images of the HA (left) and SPCL (right) scaffolds seeded with RBMSCs (1 % 106 cells/scaffold) which were stained for ALP after culturing in different
culture medium for the period of 14 d: (A, B) Controls (scaffolds without RBMSCs); (C, D) Complete MEM medium; (E, F) MEM medium with 0.01 mg ml!1 Dex-loaded CMCht/
PAMAM dendrimer nanoparticles, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate; (G, H) MEM medium supplemented with 10!8 M Dex 0.28 mM ascorbic acid and 10 mM b-
glycerophosphate (osteogenic medium).
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version of this article). Despite the high cellular density it is clear
that cells did not obstruct the pores of either. This is an important
condition, since the overall performance of the construct [38–40]
may be affected by limiting the diffusion of nutrients, oxygen, and
metabolites to or from its core.
3.3. Effect of the Dex-loaded CMCht/PAMAM dendrimer
nanoparticles on the osteogenic differentiation of rat bone marrow
stromal cells
In the present study we have also investigated the osteogenic
differentiation of RBMSCs seeded onto the surface of the HA and
SPCL scaffolds that were cultured in: (i) absence of Dex and (ii) with
Dex delivered as a medium supplement and via cellular uptake
using the CMCht/PAMAM dendrimer nanoparticles. Mendes et al.
[29] showed that the SPCL supports the proliferation and osteo-
genic differentiation of RBMSCs, in vitro. Despite the in vitro and in
vivo characterization on the performance of the SPCL scaffolds, the
report lacks in quantitative data. To our knowledge, no qualitative
and quantitative studies were performed to investigate the effect of
combining Dex-loaded CMCht/PAMAM dendrimer nanoparticles
and both HA and SPCL scaffolds (3D system) on the osteogenic
differentiation of the RBMSCs, in vitro.
Production of mineral deposits is an important indicator of
osteogenesis and osteogenic differentiation [41,42]. In order to be
able to assess mineralization, calcium staining (Alizarin red) and
SEM analyses of RBMSCs-scaffold constructs cultured in different
culture media were carried out (Fig. 7). At 14 d, it was possible to
observe a higher calcium deposition in the RBMSCs-scaffold
constructs exposed to Dex-loaded CMCht/PAMAM dendrimer
nanoparticles as compared to that of RBMSCs-scaffold constructs
cultured in the standard culture medium (Fig. 7I, K, and E, G). The
extent of mineralization in cultures exposed to Dex-loaded CMCht/
PAMAM dendrimer nanoparticles at a final concentration of
0.01 mgml!1 was of the samemagnitude as for cultures exposed to
a standard osteogenic media (Fig. 7I, K and M, O). Moreover, from
SEM images it is possible to observe the typical mineralized
nodules (Fig. 7J, L and N, P), which are not seen in RBMSCs-scaffold
constructs cultured in complete MEM medium (Fig. 7F and H).
Finally, the osteoblastic phenotype expression levels were
evaluated both, qualitatively and quantitatively for alkaline phos-
phatase and osteocalcin, which are known to be the early and late
markers of osteogenic differentiation [43], respectively. It is well
known that Dex triggers the osteogenic differentiation of MSCs at
an early stage and directs the cells toward terminal maturation at
the late stages of differentiation and matrix mineralization [44].
Thus, we hypothesized that the continuous exposure of RBMSCs to
Dex via the sustained release from the nanoparticles, either intra-
cellularly or in culture media results in the differentiation of
RBMSCs into mature osteoblasts. Fig. 8 shows the ALP staining of
RBMSCs-scaffold constructs after culturing in a different culture
medium for a period of 14 d. As seen for mineralization, the ALP
activity is higher for cultures in which RBMSCs were exposed to
Dex-loaded CMCht/PAMAM dendrimer nanoparticles and osteo-
genic medium (Fig. 8E, F and G, H). These findings demonstrate
strong evidence that osteogenic differentiation only occurred in
cultures with Dex either supplemented from culture media and
delivered via the Dex-loaded CMCht/PAMAM dendrimer
nanoparticles.
The ALP activity per DNA content of the HA (left) and SPCL
(right) scaffolds seeded with RBMSCs and cultured in different
culturemedia for a period of 12 h, 7 and 14 d is presented in Fig. 9. It
is possible to observe that ALP activity is increased in cultures
where RBMSCs-scaffold constructs were exposed to Dex, i.e. Dex-
loaded CMCht/PAMAM dendrimer nanoparticles and osteogenic
medium. The present data is not surprising, since the in vitro
release studies of Dex from the CMCht/PAMAM dendrimer nano-
particles [24] revealed that Dex concentration resembles to that of
osteogenic media. In addition, a significant increase in the ALP
activity of RBMSCs-HA scaffold constructs that were cultured with
Dex delivered via the CMCht/PAMAM dendrimer nanoparticles was
observed as compared to the constructs supplemented with Dex in
culture media, after 7 d. In contrast, the ALP activity is higher when
RBMSCs are cultured with 10!8 M Dex supplied from culture
medium (Fig. 9 right, F), after 14 d. No significant differences in the
ALP activity were observed for RBMSCs-SPCL scaffold constructs,
after 7 d although, sub-figure (right, G) shows a higher ALP activity
in the RBMSCs-SPCL constructs that were culturedwith Dex-loaded
CMCht/PAMAM dendrimer nanoparticles after 14 d. We have also
observed that ALP activity is higher for the RBMSCs-HA constructs
as compared to that for the RBMSCs-SPCL constructs. Thus, results
demonstrated that Dex-loaded CMCht/PAMAM dendrimer nano-
particles combined with HA enhance osteogenesis by increasing
ALP activity and mineralization of the extra-cellular matrix.
Therefore, the present data shows that the Dex-loaded CMCht/
PAMAM dendrimer nanoparticle may be useful in TE strategies
since it promotes the early osteogenic differentiation of RBMSCs. In
its turn, this data corroborates previous works [27,42,45] that
demonstrated the important role of HA in the adhesion, prolifera-
tion and osteogenic differentiation of the RBMSCs, in vitro and in
vivo. This data is not surprising since HA which has a crystal
structure similar to that of bone mineral [46], and are considered
Fig. 9. ALP activity per DNA content of the HA (left) and SPCL (right) scaffolds seeded with RBMSCs (1 %106 cells/scaffold) after culturing in different culture medium for the period
of 12 h, 7 and 14 d: (A, B and E) Complete MEM medium; (C, F) MEM medium supplemented with 10!8 M Dex, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate (osteogenic
medium); (D, G) MEMmediumwith 0.01 mg ml!1 Dex-loaded CMCht/PAMAM dendrimer nanoparticles, 0.28 mM ascorbic acid and 10 mM b-glycerophosphate. Results expressed as
an average $ standard deviation, n ¼ 9.
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the ‘gold-standard’ of the osteoconductive materials. The obtained
results also demonstrated that SPCL scaffolds are effective in sup-
porting the osteogenic differentiation of RBMSCs, since ALP activity
is in the same order of magnitude to that of RBMSCs-HA constructs.
On the other hand, the SPCL scaffolds have been shown [31] to be
degraded enzymatically, which allows an increase in the scaffold
porosity over time and consequently may favour tissue ingrowth
during implantation time.
Fig. 10 shows the content of the late osteogenic marker and
bone-specific osteocalcin normalized by DNA content of RBMSCs
cultured onto the surface of the HA (left) and SPCL (right) scaffolds
and exposed to a different culture medium for the period of 12 h, 7
and 14 d. This data corroborates the previous ALP assay demon-
strating that RBMSCs differentiate into osteoblasts when culturing
in the presence of Dex-loaded CMCht/PAMAM dendrimer nano-
particles and osteogenic medium. However, no significant differ-
ences in osteocalcin content were observed for the RBMSCs-HA and
RBMSCs-SPCL scaffold constructs supplemented with Dex deliv-
ered via the CMCht/PAMAM dendrimer nanoparticles and free in
culture media, after 7 and 14 d of culturing. In the light of these
results, we have shown that RBMSCs proliferated well, and both
differentiate into osteoblasts and organize into a mineralized
matrix by combining Dex-loaded CMCht/PAMAM dendrimer
nanoparticles and scaffolds (3D systems), in vitro.
This work has demonstrated the efficacy of the system Dex-
loaded CMCht/PAMAM dendrimer nanoparticles and scaffolds in
promoting the proliferation and osteodifferentiation of RBMSCs,
and the success in the intracellular delivery of Dex, in vitro. Thus, it
is conceivable that intracellular controlled drug delivery using
biodegradable nanocarriers or cell-based carrying nanoparticles’
strategies may be an excellent candidate for in vivo TE applications,
as these nanosystems may possibly to: (i) reduce the drug dosage
needs and (ii) improve efficacy, since the drug would only
concentrate in the damaged/diseased cells and tissues.
4. Conclusion
In this work we demonstrate the biological performance of
previously prepared macroporous HA and SPCL scaffolds. These
have shown to be adequate for culturing RBMSCs, namely for
adhesion, proliferation and osteogenic differentiation. Results
showed that the RBMSCs proliferation and osteogenic differentia-
tion are favored when cultured onto the surface of the HA scaffolds,
but the results obtained for SPCL are quite similar and much better
than one could expect for a biodegradable polymer. On the other
hand, the biochemical data presented herein demonstrated that the
Dex-loaded CMCht/PAMAM dendrimer nanoparticles enhanced
the early osteogenic differentiation of RBMSCs in vitro. Therefore,
the Dex-loaded CMCht/PAMAM dendrimer nanoparticles may be
used as intracellular nanocarriers of biological agents being able to
modulate the behaviour of stem cells.
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Appendix
Figures with essential colour discrimination. Certain figures
in this article, in particular Figures 6, 7 and 8, are difficult to
interpret in black and white. The full colour images can be found in
the on-line version, at doi: 10.1016/j.biomaterials.2008.10.024.
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